¼¼°èÀÇ ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Nucleic Acid Sample Preparation Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1808848
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 377 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,605,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,589,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,006,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 32¾ï 3,478¸¸ ´Þ·¯¸¦ ´Þ¼ºÇÏ¿´°í, 2025-2032³â¿¡ °ÉÃÄ CAGR 6.2%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀº ´Ù¾çÇÑ »ý¹°ÇÐÀû »ùÇÿ¡¼­ ÇÙ»ê(DNA¿Í RNA)À» ºÐ¸®, Á¤Á¦, Á¦Á¶ÇÏ°í ´Ù¿î½ºÆ®¸² ¿ëµµ¿¡ »ç¿ëÇÏ´Â Á¦Ç°, ±â¼ú, ¼­ºñ½º °³¹ß ¹× °ø±Þ¿¡ Á¾»çÇÏ´Â ¾÷°è¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ °úÁ¤Àº ºÐÀÚ Áø´Ü, À¯Àüü ¿¬±¸, »ý¸í°øÇÐ, ¹ýÀÇÇÐ ºÐ¼®¿¡¼­ Áß¿äÇÑ ´Ü°èÀÔ´Ï´Ù. Á¶Á¦µÈ ÇÙ»êÀº PCR, ½ÃÄö½Ì, À¯ÀüÀÚ ¹ßÇö ¿¬±¸ µîÀÇ ¿ëµµ¿¡¼­ Á¤È®ÇÑ °á°ú¸¦ ¾ò±â À§ÇØ °í¼øµµÀÇ ¿À¿° ¹°ÁúÀÌ ¾ø¾î¾ß ÇÕ´Ï´Ù.

»ùÇà Á¶Á¦¿¡´Â ¼¼Æ÷ ¿ëÇØ, ÇÙ»ê ÃßÃâ, Á¤Á¦, Á¤·® µîÀÇ ¿©·¯ ´Ü°è°¡ Æ÷ÇԵ˴ϴÙ. ¼öµ¿ÀûÀÎ ¹æ¹ýÀÇ ÀÎÀû ¿À·ù¸¦ ÁÙÀ̰í È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ ÀÚµ¿È­ ½Ã½ºÅÛÀ¸·Î ´ëüµË´Ï´Ù. ¼ö¿ä´Â ƯÈ÷ ¾Ï, °¨¿°, À¯Àü¼º Áúȯ µîÀÇ ÀÓ»ó Áø´Ü¿¡¼­ ÇÙ»ê ±â¹Ý °Ë»çÀÇ »ç¿ë Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·áÀÇ »ó½Â°ú À¯Àüü ¹× ´Ü¹éÁúüÇÐÀÇ Áøº¸°¡ ½ÃÀå ¹üÀ§¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ½ÇÇè½ÇÀÌ ³ôÀº 󸮷®°ú ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ ¸ñÇ¥·Î ÇÏ´Â °¡¿îµ¥, ½ÃÀåÀº ½Ã¾à, ŰƮ, ÀÚµ¿È­ ±â¼úÀÇ Çõ½Å°ú ÇÔ²² ÁøÈ­¸¦ °è¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå - ½ÃÀå ¿ªÇÐ

¾Ï Áø´Ü¿¡¼­ÀÇ ¾×ü »ý°ËÀÇ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎ

¾ÏÀÇ Áø´Ü°ú ¸ð´ÏÅ͸µÀ» À§ÇÑ ¾×ü »ý°ËÀÇ Ã¤¿ë Áõ°¡´Â ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø ¿äÀÎÀÔ´Ï´Ù. ¾×ü »ý°ËÀº Ç÷¾× »ùÇÿ¡¼­ ¼øÈ¯ Á¾¾ç DNA(ctDNA)¿Í RNA¸¦ ºÐ¼®ÇÏ¿© ±âÁ¸ÀÇ Á¶Á÷ »ý°ËÀ» ´ëüÇÏ´Â ºñħ½ÀÀû ½Ç½Ã°£ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ ¹æ¹ýÀº ³·Àº Á¸Àç·®ÀÇ ¹ÙÀÌ¿À¸¶Ä¿¸¦ °ËÃâÇϱâ À§ÇØ ¹Î°¨Çϰí È¿À²ÀûÀÎ ÇÙ»ê ÃßÃâÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. Á¤¹Ð Á¾¾çÇÐÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ½Å·Ú¼ºÀÌ ³ô°í ¼öÀ²ÀÌ ³ôÀº »ùÇà Àüó¸® ŰƮ¿Í ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â ÀÌ·¯ÇÑ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ Æ¯¼ö ÃßÃâ ±â¼úÀ» °³¹ßÇϰí ÀÖÀ¸¸ç ÀÓ»ó ¹× ¿¬±¸ ȯ°æ¿¡¼­ ½ÃÀå °³Ã´¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó Àåºñ, ¼Ò¸ðǰ, ŰƮ·Î ºÐ·ùµË´Ï´Ù. ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀº ½ÇÇè½Ç ¿öÅ©Ç÷ο쿡¼­ ±¤¹üÀ§ÇÏ°Ô Ã¤ÅÃµÇ°í ÆíÀǼº ¹× ½Å·Ú¼ºÀ» Á¦°øÇϴ ŰƮ°¡ Áö¹èÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áï½Ã »ç¿ëÇÒ ¼ö Àִ ŰƮ´Â DNA¿Í RNAÀÇ ÃßÃâÀ» È¿À²È­Çϰí, ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö¸¦ ÁÙÀ̸ç, PCR, ½ÃÄö½Ì, Áø´Ü µîÀÇ ¿ëµµ¿¡ ÇʼöÀûÀÎ ÀϰüµÈ °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ºñ¿ë È¿°ú°¡ ¶Ù¾î³ª ´Ù¾çÇÑ »ùÇà À¯Çü(Ç÷¾×, Á¶Á÷, Ÿ¾×)¿¡ ÀûÇÕÇϱ⠶§¹®¿¡ Çмú, ÀÓ»ó, Á¦¾à ½ÇÇè½Ç¿¡¼­ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÚ¼º ºñµå ±â¹Ý Á¤Á¦ ¹× Ä÷³À» »ç¿ëÇÏÁö ¾Ê´Â ¹æ¹ý µî ŰƮ ó¹æÀÇ Áøº¸°¡ ¼öÀ²°ú ¼øµµ¸¦ ³ôÀÌ°í ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È­¿¡ ÀûÇÕÇÑ Å°Æ®´Â °í󸮷® ¿öÅ©Ç÷ο츦 Áö¿øÇϸç À¯ÀüüÇÐ ¹× Á¤¹Ð ÀÇ·á¿¡¼­ È®Àå °¡´ÉÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú, ŰƮ´Â ÃÖ´ë ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú Áø´Ü ¿ëµµÀÇ È®´ë·Î ¾ÕÀ¸·Îµµ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ´Ü¹éÁú Àüó¸®, °í»ó ÃßÃâ, ¾×ü ¾×ü ÃßÃâ·Î ºÐ·ùµË´Ï´Ù. °í»ó ÃßÃâ(SPE)Àº ÇÙ»ê »ùÇà Á¦Á¶ ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ ±â¼úÀ̸ç, È¿À²¼º, È®À强, °í¼øµµ ¼öÀ²·Î ÀÎÇØ ³Î¸® ÁöÁöµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ½Ç¸®Ä« ±â¹Ý Ä÷³ ¶Ç´Â ÀÚ¼º ºñµå¸¦ »ç¿ëÇÏ¿© º¹ÀâÇÑ »ý¹°ÇÐÀû »ùÇÿ¡¼­ ÇÙ»êÀ» °áÇÕ ¹× ºÐ¸®ÇÏ´Â °ÍÀ¸·Î, PCR, NGS, ÀÓ»ó Áø´Ü µîÀÇ ¿ëµµ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. SPE´Â °í󸮷® ½ÇÇè½Ç ¹× Á¤¹Ð ÀÇ·á ¿öÅ©Ç÷ο쿡 ÇʼöÀûÀÎ ¶Ù¾î³­ ÀçÇö¼º°ú ÀÚµ¿È­¿¡ ´ëÇÑ ÀûÇÕ¼ºÀ» Á¦°øÇÕ´Ï´Ù.

¾×ü ÃßÃâ(½Ã°£ÀÌ ¸¹ÀÌ °É¸®°í ´ë·®ÀÇ ¿ë¸Å »ç¿ë) ¹× ´Ü¹éÁú Á¶Á¦(ƯÁ¤ »ùÇà À¯ÇüÀ¸·Î Á¦ÇÑ)¿Í ºñ±³ÇÏ¿©, SPE´Â ƯÈ÷ ¾×ü »ý°ËÀÇ ctDNA¿Í °°Àº Àú³óµµ Ÿ°Ù¿¡ ´ëÇØ º¸´Ù ½Å¼ÓÇÑ Ã³¸®, ¿À¿° À§Çè °¨¼Ò, ¿ì¼öÇÑ È¸¼öÀ²À» Á¦°øÇÕ´Ï´Ù. ÀÚµ¿È­ ½Ã½ºÅÛ°ú ŰƮ¿¡ ´ëÇÑ ÀûÀÀ¼ºÀº SPEÀÇ ÁÖµµÀû ÁöÀ§¸¦ ´õ¿í °ß°íÇÏ°Ô ÇÏ°í ¿¬±¸, Áø´Ü, ÀǾàǰ °³¹ß¿¡¼­ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºñµå ±â¹Ý SPE ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀº ½ÃÀå¿¡¼­ SPEÀÇ Áö¼ÓÀûÀÎ ÀÌÁ¡À» º¸ÀåÇÕ´Ï´Ù.

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹ÌÀÇ ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀº ÷´Ü °Ç°­ °ü¸® ÀÎÇÁ¶ó, ¿Õ¼ºÇÑ ¿¬±¸°³¹ß ÅõÀÚ, Á¤¹Ð ÀÇ·áÀÇ º¸±ÞÀ¸·Î ¼¼°èÀûÀ¸·Î ¿ìÀ§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ´Â »ý¸í°øÇÐÀÇ ÁÖ¿ä °ÅÁ¡(º¸½ºÅÏ, »÷ÇÁ¶õ½Ã½ºÄÚ), ÁÖ¿ä ±â¾÷(Thermo Fisher, Illumina, Agilent)ÀÇ Á¸Àç°¨, NGS ±â¹Ý Áø´Ü°ú ¾×ü »ý°Ë¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä°¡ ¹è°æ¿¡ ÀÖ½À´Ï´Ù. ij³ª´Ù´Â À¯Àüü ¿¬±¸(Genome Canada µî)¿Í Çмú ¿¬±¸°¡ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÀÚµ¿È­ ¹× °í󸮷® ÃßÃ⠽ýºÅÛÀÌ ¿ì¼±½ÃµÇ¾î ÀÓ»ó½ÇÇè½Ç ¹× Á¦¾à ºÐ¾ß¸¦ ¼±µµÇÕ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø(FDA, CLIA)Àº »ó¿ëÈ­¸¦ °¡¼ÓÈ­Çϰí, ¾Ï°ú °¨¿°Áõ °Ë»ç Áõ°¡´Â ŰƮ¿Í ¼Ò¸ðǰÀÇ ÆÇ¸Å¸¦ ¹Ð¾î¿Ã¸³´Ï´Ù. °æÀïÀº Ä¡¿­Çϰí, °¢ ȸ»ç´Â ÆÒµ¥¹Í ´ëÃ¥°ú °³ÀÎÈ­ Ä¡·áÀÇ µ¿Çâ¿¡ ´ëÀÀÇϱ⠶§¹®¿¡ ½Å¼ÓÇÑ ÈÞ´ë¿ë ¼Ö·ç¼Ç(Æ÷ÀÎÆ® ¿Àºê Äɾî DNA ÃßÃâ µî)¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀåÀº AI ÅëÇÕ Ç÷§ÆûÀ̳ª Áø´Ü ³×Æ®¿öÅ©¿ÍÀÇ Á¦ÈÞ°¡ ¿øµ¿·ÂÀÌ µÇ¾î È®´ë¸¦ Áö¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå - °æÀï ±¸µµ

ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀÇ °æÀï ±¸µµ´Â ±Þ¼ºÀå ºÐ¾ß¿¡¼­ ÆÐ±ÇÀ» ´ÙÅõ´Â ±âÁ¸ ±â¾÷°ú Çõ½ÅÀû ½ÅÈï ±â¾÷ °£ÀÇ °Ý·ÄÇÑ Àû´ë °ü°è°¡ Ư¡ÀÔ´Ï´Ù. Thermo Fisher Scientific, QIAGEN, Roche´Â ÀÚµ¿ ÃßÃ⠽ýºÅÛ, °í¼º´É ŰƮ, ¼¼°è ÃÖÁ¾ »ç¿ëÀÚ ³×Æ®¿öÅ© µî ±¤¹üÀ§ÇÑ Æ÷Æ®Æú¸®¿À¸¦ ¹«±â·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼±µµ ±â¾÷µéÀº ±â¼ú Çõ½Å(ÀÚ¼º ºñµå ±â¹Ý ÃßÃâ, ÈÞ´ë¿ë Àåºñ µî)°ú Àü·«Àû Àμö·Î °æÀïÇÏ°í µµ´Þ ¹üÀ§¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù.

Agilent, Bio-Rad, Merck KGaA¿Í °°Àº Áß°ß ±â¾÷Àº NGS ¹× CRISPR ±â¹Ý ¿öÅ©Ç÷οì¿Í °°Àº Æ´»õ ¿ëµµ¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ½ÅÈï ±â¾÷(Zymo Research, Norgen Biotek)Àº ¾×ü »ý°Ë ¹× ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ¿¬±¸¸¦ À§ÇÑ ºñ¿ëÈ¿À²ÀûÀΠƯ¼ö ŰƮ·Î ½ÃÀåÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. Beckman Coulter(Danaher)¿Í PerkinElmer´Â °í󸮷® Ç÷§Æû¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â MGI Tech(Áß±¹)¿Í Takara Bio(ÀϺ»)°¡ °ßÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ½ÃÀå Àü¸ÁÀº Á¤¹Ð ÀÇ·á ¼ö¿ä, Áø´Ü½ÇÇè½Ç°úÀÇ Á¦ÈÞ, ½ÅÈï ±¹°¡ÀÇ È®À强¿¡ ´Þ·Á ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇÙ»ê »ùÇà Á¶Á¦ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÇÙ»ê »ùÇà Á¶Á¦ »ê¾÷ÀÇ Á¶»ç

Á¦5Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå : Áõ°¡ÇÏ´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀåÀÇ »óȲ

Á¦7Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå : ¿ëµµº°

Á¦9Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ÇÙ»ê »ùÇà Á¶Á¦ ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÇÙ»ê »ùÇà Á¶Á¦ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¾ÇÕÀû Àü¸Á

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Nucleic Acid Sample Preparation Market size was valued at US$ 3,234.78 Million in 2024, expanding at a CAGR of 6.2% from 2025 to 2032.

The Nucleic Acid Sample Preparation Market refers to the industry involved in developing and supplying products, technologies, and services used to isolate, purify, and prepare nucleic acids (DNA and RNA) from various biological samples for downstream applications. This process is a critical step in molecular diagnostics, genomic research, biotechnology, and forensic analysis. The prepared nucleic acid must be of high purity and free of contaminants to ensure accurate results in applications such as PCR, sequencing, and gene expression studies.

Sample preparation includes multiple steps like cell lysis, nucleic acid extraction, purification, and quantification. Manual methods are being increasingly replaced by automated systems to reduce human error and enhance efficiency. The demand is fueled by the growing use of nucleic acid-based testing in clinical diagnostics, particularly for cancer, infectious diseases, and genetic disorders. Additionally, the rise of personalized medicine and advancements in genomics and proteomics are expanding the market's scope. As laboratories aim for high-throughput and reliable results, the market continues to evolve with innovations in reagents, kits, and automation technologies.

Nucleic Acid Sample Preparation Market- Market Dynamics

Rising demand for liquid biopsy in cancer diagnostics drives market growth

The increasing adoption of liquid biopsy for cancer detection and monitoring is a key driver for the nucleic acid sample preparation market. Liquid biopsies analyze circulating tumor DNA (ctDNA) and RNA from blood samples, offering a non-invasive, real-time alternative to traditional tissue biopsies.

This method requires highly sensitive and efficient nucleic acid extraction to detect low-abundance biomarkers. As precision oncology advances, demand for reliable, high-yield sample prep kits and automated systems grows. Companies are developing specialized extraction technologies to meet these needs, fueling market expansion in clinical and research settings.

Nucleic Acid Sample Preparation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2025-2032)

Based on product type segmentation, kits segment was predicted to show maximum market share in the year 2024

Based on application segmentation, Solid-phase extraction (SPE) was the leading application in 2024

Based on End-user segmentation, Hospitals was the leading End-user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Nucleic Acid Sample Preparation Market- Segmentation Analysis:

The Global Nucleic Acid Sample Preparation Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into three categories based on product type: Instruments, Consumables, and Kits. The kits segment dominates the nucleic acid sample preparation market due to its widespread adoption, convenience, and reliability in laboratory workflows. These ready-to-use kits streamline DNA and RNA extraction, reducing manual errors and ensuring consistent results, critical for applications like PCR, sequencing, and diagnostics. Their cost-effectiveness and compatibility with various sample types (blood, tissue, saliva) make them a preferred choice for academic, clinical, and pharmaceutical labs.

Additionally, advancements in kit formulations, such as magnetic bead-based purification and column-free methods, enhance yield and purity, further driving demand. Automation-friendly kits also support high-throughput workflows, catering to the growing need for scalable solutions in genomics and precision medicine. As a result, kits hold the largest revenue share and are expected to maintain dominance due to continuous innovation and expanding diagnostic applications.

The market is divided into three categories based on application: Protein Preparation, Solid-phase extraction, and Liquid-liquid extraction. Solid-phase extraction (SPE) is the dominant technique in the nucleic acid sample preparation market, widely favored for its efficiency, scalability, and high purity yields. This method uses silica-based columns or magnetic beads to bind and isolate nucleic acids from complex biological samples, making it ideal for applications like PCR, NGS, and clinical diagnostics. SPE offers superior reproducibility and automation compatibility, which is critical for high-throughput labs and precision medicine workflows.

Compared to liquid-liquid extraction (time-consuming and solvent-heavy) and protein preparation (limited to specific sample types), SPE provides faster processing, reduced contamination risks, and better recovery rates, especially for low-concentration targets like ctDNA in liquid biopsies. Its adaptability to automated systems and kits further cements SPE's leading position, driving adoption in research, diagnostics, and pharmaceutical development. Continuous advancements in bead-based SPE technologies ensure its sustained dominance in the market.

Nucleic Acid Sample Preparation Market- Geographical Insights

The North American nucleic acid sample preparation market dominates globally, driven by advanced healthcare infrastructure, robust R&D investments, and widespread adoption of precision medicine. The U.S. accounts for the largest share, fueled by leading biotech hubs (Boston, San Francisco), strong presence of key players (Thermo Fisher, Illumina, Agilent), and high demand for NGS-based diagnostics and liquid biopsies. Canada follows, with growth propelled by genomics initiatives (e.g., Genome Canada) and academic research.

Automation and high-throughput extraction systems are prioritized, catering to clinical labs and pharmaceutical giants. Regulatory support (FDA, CLIA) accelerates commercialization, while rising cancer and infectious disease testing boosts kit and consumable sales. Competition is intense, with firms focusing on portable, rapid solutions (e.g., point-of-care DNA extraction) to address pandemic preparedness and personalized therapy trends. The region's market will continue expanding, driven by AI-integrated platforms and partnerships with diagnostic networks.

Nucleic Acid Sample Preparation Market- Competitive Landscape:

The competitive landscape of the nucleic acid sample preparation market is characterized by intense rivalry among established players and innovative startups, all vying for dominance in a rapidly growing sector. Thermo Fisher Scientific, QIAGEN, and Roche lead the market, leveraging their extensive portfolios of automated extraction systems, high-performance kits, and global End-user networks. These giants compete on technology innovation (e.g., magnetic bead-based extraction, portable devices) and strategic acquisitions to expand their reach.

Mid-tier players like Agilent, Bio-Rad, and Merck KGaA focus on niche applications, such as NGS and CRISPR-based workflows, while emerging companies (Zymo Research, Norgen Biotek) disrupt the market with cost-effective, specialty kits for liquid biopsies and microbiome studies. Automation and AI-driven solutions are becoming key differentiators, with firms like Beckman Coulter (Danaher) and PerkinElmer investing heavily in high-throughput platforms. Regional dynamics also play a role, with MGI Tech (China) and Takara Bio (Japan) gaining traction in Asia-Pacific. The market's future will hinge on precision medicine demand, partnerships with diagnostic labs, and scalability in emerging economies.

Recent Developments:

In June 2024, Thermo Fisher Scientific launched the KingFisher(TM) PurePlus system, enhancing automated nucleic acid extraction for high-throughput labs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Nucleic Acid Sample Preparation Market Overview

2. Executive Summary

3. Nucleic Acid Sample Preparation Key Market Trends

4. Nucleic Acid Sample Preparation Industry Study

5. Nucleic Acid Sample Preparation Market: Impact of Escalating Geopolitical Tensions

6. Nucleic Acid Sample Preparation Market Landscape

7. Nucleic Acid Sample Preparation Market - By Product Type

8. Nucleic Acid Sample Preparation Market - By Application

9. Nucleic Acid Sample Preparation Market - By End-user

10. Nucleic Acid Sample Preparation Market- By Geography

11. Key Vendor Analysis- Nucleic Acid Sample Preparation Industry

12. 360 Degree AnalystView

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â